https://thebostonexaminer.com/article/905493565-choate-expands-fund-formation-and-investment-management-practice-with-former-lowenstein-partner-jonathan-danziger The Boston Examiner en PressRelease 2026-04-13T15:05:20+00:00 Choate Expands Fund Formation and Investment Management Practice with Former Lowenstein Partner Jonathan Danziger https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/15938189-choate-logo-1962x313.png https://thebostonexaminer.com/article/904937665-seacoast-ai-uses-leverage-s-sovereign-ai-to-put-its-data-to-work The Boston Examiner en PressRelease 2026-04-13T14:38:00+00:00 Seacoast AI Uses Leverage’s Sovereign AI to Put Its Data to Work https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830795-seacoast-ai-1920x1080.png https://thebostonexaminer.com/article/905025517-town-of-millbury-partners-with-planetbids-to-modernize-and-streamline-procurement-processes The Boston Examiner en PressRelease 2026-04-13T13:00:00+00:00 Town of Millbury Partners with PlanetBids to Modernize and Streamline Procurement Processes https://thebostonexaminer.com/article/901452671-imex-cargo-expands-workforce-development-strategy-to-power-digital-freight-infrastructure-through-plug-in-freight-ops The Boston Examiner en PressRelease 2026-04-13T12:00:00+00:00 ‘ImEx Cargo Expands Workforce Development Strategy to Power Digital Freight Infrastructure Through Plug-In Freight Ops™’ https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24814451-imex-cargo-academy-preparing-ta-500x500.png https://thebostonexaminer.com/article/905465559-influential-women-profiles-kim-shivers-championing-people-first-leadership-through-value-your-people-consulting The Boston Examiner en PressRelease 2026-04-13T11:02:34+00:00 Influential Women Profiles Kim Shivers: Championing People-First Leadership Through Value Your People Consulting https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831229-kim-shivers-394x404.png https://thebostonexaminer.com/article/905389327-boston-pads-database-surpasses-300-000-units-expanding-footprint-beyond-greater-boston The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 Boston Pads Database Surpasses 300,000 Units, Expanding Footprint Beyond Greater Boston https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24581669-boston-pads-320x320.jpeg https://thebostonexaminer.com/article/905402725-sunway-medical-centre-penang-recognized-as-emerging-tertiary-medical-hub-malaysia-by-global-brand-frontier-awards-2025 The Boston Examiner en PressRelease 2026-04-13T05:38:09+00:00 Sunway Medical Centre Penang Recognized as Emerging Tertiary Medical Hub – Malaysia by Global Brand Frontier Awards 2025 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830973-sunway-medical-main-3750x1969.jpeg https://thebostonexaminer.com/article/905496045-sentinel-group-strengthens-growth-strategy-with-two-senior-leadership-appointments The Boston Examiner en PressRelease 2026-04-13T15:14:12+00:00 Sentinel Group Strengthens Growth Strategy with Two Senior Leadership Appointments https://ml.globenewswire.com/media/aacb4399-9cc2-42d0-b1f0-675cc62d7d92/medium/headshots.png https://thebostonexaminer.com/article/905483267-merlin-further-expands-executive-team-appointing-mark-brunner-as-chief-revenue-officer The Boston Examiner en PressRelease 2026-04-13T13:20:13+00:00 Merlin Further Expands Executive Team Appointing Mark Brunner as Chief Revenue Officer https://ml.globenewswire.com/media/368ea8dd-210e-4fb6-9c0c-887bc5643e29/medium/mark-brunner.png https://thebostonexaminer.com/article/905478638-microbot-medical-commences-full-market-release-fmr-of-the-liberty-endovascular-robotic-system-in-the-u-s-at-the-society-of-interventional The Boston Examiner en PressRelease 2026-04-13T12:30:00+00:00 Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://thebostonexaminer.com/article/905474861-mks-inc-announces-first-quarter-2026-earnings-conference-call The Boston Examiner en PressRelease 2026-04-13T12:00:00+00:00 MKS Inc. Announces First Quarter 2026 Earnings Conference Call https://ml.globenewswire.com/media/a922cdbe-9964-4f52-86d5-ff5e42639bb0/small/mks-color-logo-jpg.jpg https://thebostonexaminer.com/article/905475009-praxis-to-showcase-essential3-the-first-positive-phase-3-program-in-essential-tremor-at-aan-2026 The Boston Examiner en PressRelease 2026-04-13T12:00:00+00:00 Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026 https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://thebostonexaminer.com/article/905475064-akebia-therapeutics-announces-first-participants-dosed-in-phase-1-clinical-trial-of-akb-9090 The Boston Examiner en PressRelease 2026-04-13T12:00:00+00:00 Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090 https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://thebostonexaminer.com/article/905466972-kymera-therapeutics-announces-u-s-fda-fast-track-designation-for-kt-621-a-first-in-class-oral-stat6-degrader-for-the-treatment-of-moderate-to The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://thebostonexaminer.com/article/905466973-spyre-announces-potential-best-in-class-spy001-part-a-induction-results-from-skyline-trial-in-moderate-to-severe-ulcerative-colitis-patients The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://thebostonexaminer.com/article/905466986-ocular-therapeutix-announces-additional-positive-week-52-data-from-landmark-sol-1-phase-3-trial-of-axpaxli-in-wet-amd The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://thebostonexaminer.com/article/905467081-imagenebio-announces-30-million-private-placement The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 ImageneBio Announces $30 Million Private Placement https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg